- 3101. Donitriptan
- (UMLS (NCI) C0769585) =Organic Chemical; Pharmacologic Substance ;
| - 3151. Dorsal Nucleus of the Vagus Nerve
- (UMLS (NCI) C0926535) nucleus alaris;
nucleus dorsalis nervi vagi;
nucleus vagalis dorsalis =Body Part, Organ, or Organ Component |
- 3102. Donnan effect on cell
- [ ] (UMLS (CSP) C0684211) =Organ or Tissue Function ;
| - 3152. Dorsal or lateral slit of prepuce
- [ ] (UMLS (ICD9CM) C0177145) =Therapeutic or Preventive Procedure
|
- 3103. Donnatal
- [A combination agent, comprised of belladonna alkaloids and Phenobarbital, with gastrointestinal anticholinergic activity. The belladonna alkaloids produce an anticholinergic effect by the competitive inhibition of acetylcholine at the parasympathetic neuro-effector junction, and the barbiturates produce a sedative effect probably as a result of their inhibition of synaptic neurotransmitters in the central nervous system (CNS). ( NCI )] (UMLS (NCI) C0378883) =Organic Chemical; Pharmacologic Substance
| - 3153. dorsal raphe nucleus
- [nucleus of closely packed, deeply staining cells in the ventral part of the periaqueductal gray; a major source of ascending, serotonergic fibers; appear to be important in regulation of sleep. ( CSP )] (UMLS (CSP) C0175392) =Body Part, Organ, or Organ Component =mesencephalon;
|
- 3104. Donor
- [In some organ transplantation services and rarely in transfusion services a donor will be a target participant in the service. However, in most cases transplantation is decomposed in three services: explantation, transport, and implantation. The identity of the donor (recipient) is often irrelevant for the explantation (implantation) service. ( HL7V3.0 )] (UMLS (HL7) C1547101) =Idea or Concept =Relationship modifier;
direct target | - 3154. Dorsal Region of Foot
- (UMLS (NCI) C0230462) =Body Part, Organ, or Organ Component
|
- 3105. Donor
- [One that contributes something. ( NCI )] (UMLS (NCI) C0013018) =Human
| - 3155. dorsal respiratory center
- [ ] (UMLS (CSP) C1537009) =Body Location or Region
|
- 3106. Donor
- [individual organism that supplies tissue to be used in another body, as a person who furnishes an organ for transplantation in a histocompatible recipient. ( CSP )] (UMLS (NCI) C0040288) =Population Group =tissue resource/registry;
=blood donor;
| - 3156. dorsal root
- [comprises the central branches of the dorsal root ganglion cells and connects to the gray matter of the spinal cord; each spinal nerve has one. ( CSP )] (UMLS (CSP) C0205955) =Body Part, Organ, or Organ Component ;
=Medulla Spinalis;
|
- 3107. Donor Registration Number
- (UMLS (HL7) C1549696) =Intellectual Product =Identifier type;
| - 3157. dorsal root ganglion
- [ganglion found on the posterior root of each spinal nerve, composed of the unipolar nerve cell bodies of the sensory neurons of the nerve. ( CSP )] (UMLS (CSP) C0017070) =Body Part, Organ, or Organ Component ;
=ganglion;
|
- 3108. Donors of other specified organ or tissue
- [ ] (UMLS (ICD9CM) C0260790) =Population Group
| - 3158. DORSAL ROOT INJURY
- [ ] (UMLS (ICD9CM) C1536686) Injury to dorsal nerve root;
=Injury or Poisoning; ;
|
- 3109. Donors of unspecified organ or tissue
- (UMLS (ICD9CM) C0013019) =Finding
| - 3159. Dorsal Thalamus
- (UMLS (NCI) C0699836) =Body Part, Organ, or Organ Component ;
|
- 3110. Door
- [The entrance through which you enter or leave a room or building used as an element of an address. ( NCI )] (UMLS (NCI) C0557698) =Manufactured Object
| - 3160. Dorsal Thoracic Artery
- (UMLS (NCI) C0933449) Thoracodorsal Artery;
=Body Part, Organ, or Organ Component |
- 3111. DOPA decarboxylase
- [One of the AROMATIC-L-AMINO-ACID DECARBOXYLASES, this enzyme is responsible for the conversion of dopa to dopamine. It is of clinical importance in the treatment of Parkinson's disease. EC 4.1.1.28. ( MSH )] (UMLS (CSP) C0003806) =Amino Acid, Peptide, or Protein; Enzyme
| - 3161. Dorsal [thoracic] spinal cord injury without evidence of spinal bone injury
- [ ] (UMLS (ICD9CM) C0161426) =Injury or Poisoning
|
- 3112. DOPA decarboxylase inhibitor
- [ ] (UMLS (CSP) C0598272) =Organic Chemical; Pharmacologic Substance ;
| - 3162. Dorsal-Ventral Pattern Formation
- [Dorsal-Ventral Pattern Formation is a developmental morphogenetic process that establishes the basic configuration of cellular organization necessary for further and accurate development of the spatial arrangement of embryonic tissue along the dorsal-ventral axis. ( NCI )] (UMLS (NCI) C1160449) =Organ or Tissue Function ;
|
- 3113. DOPAC
- [A deaminated metabolite of LEVODOPA. ( MSH )] (UMLS (CSP) C0000376) =Organic Chemical; Biologically Active Substance ;
| - 3163. Dorsalis Pedis Artery
- (UMLS (NCI) C0226492) =Body Part, Organ, or Organ Component
|
- 3114. Dopaflex
- (UMLS (NCI) C1449995) =Amino Acid, Peptide, or Protein; Pharmacologic Substance
| - 3164. Dorsalis Pedis Artery Branch
- (UMLS (NCI) C1282117) =Body Part, Organ, or Organ Component
|
- 3115. Dopamet
- (UMLS (NCI) C0591404) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
| - 3165. Dorsomedial Nucleus of the Thalamus
- [The largest of the medial nuclei of the thalamus. It makes extensive connections with most of the other thalamic nuclei. ( MSH )] (UMLS (NCI) C0228329) =Body Part, Organ, or Organ Component
|
- 3116. dopamine
- [one of the catecholamine neurotransmitters in the brain; it is derived from tyrosine and is the precursor to norepinephrine and epinephrine; dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement; dopamine receptors mediate its action. ( CSP )] (UMLS (CSP) C0013030) =Organic Chemical; Pharmacologic Substance; Neuroreactive Substance or Biogenic Amine =catecholamine;
Neurotransmitter;
Dopamine Agonist;
[AU100] SYMPATHOMIMETICS (ADRENERGICS) =DARPP;
DOPAMINE HYDROCHLORIDE;
| - 3166. DORSOPATHIES
- [condition in which there is a deviation from or interruption of the normal structure or function of the spine. ( CSP )] (UMLS (ICD9CM) C0037933) =Disease or Syndrome ;
=Bone Diseases;
skeletal disorder =Sciatia;
scoliosis;
INFLAM SPONDYLOPATHY NOS;
spondylarthropathy;
Intervertebral Disk Displacement;
Platybasia;
JUV OSTEOCHONDROS SPINE;
Curvature of spine;
Intraspinal Neoplasm;
Spinal Osteophytosis;
Spinal Stenosis;
INFLAM SPONDYLOPATHY NOS;
Spondylolisthesis;
Pott's Disease;
Ossification of Posterior Longitudinal Ligament |
- 3117. Dopamine Agonist
- [class of drugs and natural products which enhance dopaminergic function by increasing dopamine biosynthesis, decreasing dopamine degradation or reuptake, or interacting positively with dopamine receptors. ( CSP )] (UMLS (NCI) C0178601) =Pharmacologic Substance =neuropharmacologic agent;
neurotransmitter agonist;
Dopamine Receptor Interactions;
=apomorphine;
2-Bromo-alpha-ergocryptine;
cocaine;
dihydroxyphenylalanine;
dopamine;
PERGOLIDE;
FENOLDOPAM | - 3167. Dorsum of the Tongue
- (UMLS (NCI) C0226952) =Body Part, Organ, or Organ Component
|
- 3118. Dopamine Antagonist
- [class of drugs and natural products which inhibit dopaminergic function by decreasing dopamine biosynthesis, increasing dopamine degradation or reuptake, or interacting negatively with dopamine receptors. ( CSP )] (UMLS (NCI) C0242702) =Pharmacologic Substance; Neuroreactive Substance or Biogenic Amine =catecholamine inhibitor;
Dopamine Receptor Interactions =methylphenyltetrahydropyridine;
4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-1-butanone;
raclopride;
SCH 23390;
2,4,5-Trihydroxyphenethylamine | - 3168. Dorsum/Dorsal
- (UMLS (HL7) C1550247) =Body Location or Region =Body Part;
|
- 3119. dopamine hydroxylase inhibitor
- [any substance or agent which suppresses, prevents or opposes the action of dopamine hydroxylase which catalyzes the biosynthesis of norepinephrine from dopamine. ( CSP )] (UMLS (CSP) C0596457) =Pharmacologic Substance =oxidoreductase inhibitor;
| - 3169. DORZOLAMIDE
- [An inhibitor of carbonic anhydrase, a zinc-containing enzyme that catalyzes the rapid conversion of carbon dioxide and water into carbonic acid, protons and bicarbonate ions. Distributed throughout many cells and tissues, various carbonic anhydrases play important roles in mineral and metabolic homeostasis. (NCI04) ( NCI )] (UMLS (NCI) C0165590) =Organic Chemical; Pharmacologic Substance =sulfonamide;
Thiophenes;
[OP104] CARBONIC ANHYDRASE INHIBITORS, SYSTEMIC OPHTHALMIC;
=Dorzolamide Hydrochloride |
- 3120. dopamine receptor
- [family of G protein-coupled receptors of two general classes: D1 (- A, -B) stimulation increases intracellular cAMP, whereas D2, D3, or D4 stimulation decreases cAMP, increases K+ flux, or decreases Ca++ flux. ( CSP )] (UMLS (CSP) C0034798) =Amino Acid, Peptide, or Protein; Receptor ;
=neurotransmitter receptor;
| - 3170. Dorzolamide Hydrochloride
- [The hydrochloride salt form of dorzolamide, an inhibitor of carbonic anhydrase, a zinc-containing enzyme that catalyzes the rapid conversion of carbon dioxide and water into carbonic acid, protons and bicarbonate ions. Distributed throughout many cells and tissues, various carbonic anhydrases play important roles in mineral and metabolic homeostasis. (NCI04) ( NCI )] (UMLS (NCI) C0771293) DORZOLAMIDE HYDROCHLORIDE PREPARATION;
=Organic Chemical; Pharmacologic Substance =DORZOLAMIDE;
=DORZOLAMIDE HYDROCHLORIDE 2 %;
|
- 3121. Dopamine Receptor D1
- [Dopamine Receptor D1, encoded by the human DRD1 gene, is the most abundant dopamine receptor in the central nervous system. This G-protein coupled receptor stimulates adenylyl cyclase and activates cyclic AMP-dependent protein kinases. It regulates neuronal growth and development, mediates some behavioral responses, and modulates dopamine receptor D2-mediated events. Alternate transcription initiation sites result in two transcript variants of this gene. (From LocusLink and NCI) ( NCI )] (UMLS (NCI) C1367800) DRD1;
DRD1 Protein =Amino Acid, Peptide, or Protein; Receptor | - 3171. DOSAG FAIL-SHOCK THERAPY
- [ ] (UMLS (ICD9CM) C0261548) =Injury or Poisoning
|
- 3122. Dopamine Receptor D1 Gene
- [This gene is involved in the regulation of dopamine receptor transport and neuronal signal transduction pertaining to neuronal growth and development. ( NCI )] (UMLS (NCI) C1333250) DRD1;
DRD1 Gene;
=Gene or Genome ;
| - 3172. Dosage Form
- [forms in which chemical products can be manufactured or administered. ( CSP )] (UMLS (NCI) C0013058) =Biomedical or Dental Material =DDS;
|
- 3123. Dopamine Receptor D2 A1 Allele
- [Human DRD2 Gene at 11q23 encodes Dopamine Receptor D2, a G-protein coupled receptor that inhibits adenylyl cyclase activity. Missense mutation in DRD2 causes myoclonus dystonia; other mutations have been associated with schizophrenia. Alternative splicing results in two different isoforms. A third variant has been described, but it has not been determined whether this form is normal or due to aberrant splicing. Different alleles are associated with increased incidence of substance abuse. The A1 allele has been associated with alcoholism. (NCI) ( NCI )] (UMLS (NCI) C1333251) DRD2 1 Allele;
DRD2 A1 Allele;
=Gene or Genome ;
| - 3173. Dosage problem
- [Proposed dosage instructions for therapy differ from standard practice. ( HL7V3.0 )] (UMLS (HL7) C1553548) =Intellectual Product =AdministrationDetectedIssueCode;
=High Dose Alert;
Low Dose Alert;
Dose-Interval Alert;
Dose-Duration Alert |
- 3124. Dopamine Receptor D2 A2 Allele
- [Human DRD2 Gene at 11q23 encodes Dopamine Receptor D2, a G-protein coupled receptor that inhibits adenylyl cyclase activity. Missense mutation in DRD2 causes myoclonus dystonia; other mutations have been associated with schizophrenia. Alternative splicing results in two different isoforms. A third variant has been described, but it has not been determined whether this form is normal or due to aberrant splicing. Different alleles are associated with increased incidence of substance abuse. (NCI) ( NCI )] (UMLS (NCI) C1333252) DRD2 2 Allele;
DRD2 A2 Allele;
=Gene or Genome ;
| - 3174. Dose med or substance
- (UMLS (HL7) C1546603) =Intellectual Product =Specimen Source Codes;
|
- 3125. Dopamine Receptor D2 Gene
- [This gene plays an inhibitory role in the regulation of adenylyl cyclase activity. ( NCI )] (UMLS (NCI) C1333253) DRD2;
DRD2 Gene;
=Gene or Genome ;
| - 3175. Dose med or substance
- (UMLS (HL7) C1550627) =Substance =SpecimenEntityType;
|
- 3126. Dopamine Receptor D4 Gene
- [This gene plays a role in G protein-coupled receptor signal transduction and inhibits adenylyl cyclase activity. ( NCI )] (UMLS (NCI) C1333254) DRD4;
DRD4 Gene;
=Gene or Genome ;
| - 3176. Dose response observed
- (UMLS (HL7) C1546996) =Idea or Concept =Causality Observations;
|
- 3127. Dopamine Receptor D5 Gene
- [This gene plays a regulatory role in adenylate cyclase activity and intracellular cAMP store accumulation. The gene is thought to act as a stimulus in both activities. ( NCI )] (UMLS (NCI) C1333255) DRD5;
DRD5 Gene;
=Gene or Genome ;
| - 3177. Dose-Duration Alert
- [Proposed length of therapy differs from standard practice. ( HL7V3.0 )] (UMLS (HL7) C1555279) =Intellectual Product =Dosage problem;
=Dose-Duration Low Alert;
Dose-Duration High Alert |
- 3128. dopamine uptake complex
- [A dopamine plasma membrane transporter protein complex located on the membrane of dopaminergic neurons. The complex includes homo-oligomers of the DAT Dopamine Transporter. ( MSH )] (UMLS (CSP) C0114839) =Amino Acid, Peptide, or Protein; Receptor ;
| - 3178. Dose-Duration High Alert
- [Proposed length of therapy is longer than standard practice ( HL7V3.0 )] (UMLS (HL7) C1555281) =Intellectual Product =Dose-Duration Alert;
=Dose-Duration High for Indication Alert;
|
- 3129. Doppler blood flow measurement
- [ ] (UMLS (CSP) C0599582) =Diagnostic Procedure ;
| - 3179. Dose-Duration High for Indication Alert
- [Proposed length of therapy is longer than standard practice for the identified indication or diagnosis ( HL7V3.0 )] (UMLS (HL7) C1555538) =Intellectual Product =Dose-Duration High Alert;
|
- 3130. Doppler blood flowmeter
- [ ] (UMLS (CSP) C0599583) =Manufactured Object ;
| - 3180. Dose-Duration Low Alert
- [Proposed length of therapy is shorter than that necessary for therapeutic effect ( HL7V3.0 )] (UMLS (HL7) C1555280) =Intellectual Product =Dose-Duration Alert;
=Dose-Duration Low for Indication Alert;
|
- 3131. Doppler Echocardiography
- [A procedure that uses sound waves to measure characteristics of disturbed bood flow, such as direction, velocity and turbulence. This enables the examiner to differentiate between normal and abnormal flow patterns and, in some cases, to quantitate those characteristics that are helpful in determining the severity of abnormal flow states. ( NCI )] (UMLS (NCI) C0013520) =Diagnostic Procedure ;
| - 3181. Dose-Duration Low for Indication Alert
- [Proposed length of therapy is shorter than standard practice for the identified indication or diagnosis ( HL7V3.0 )] (UMLS (HL7) C1555539) =Intellectual Product =Dose-Duration Low Alert;
|
- 3132. Doppler OCT
- [Optical Coherence Tomography (OCT) combines the principles of ultrasound with the imaging performance of a microscope. OCT uses infrared light waves that reflect off the internal microstructure within the biological tissues. The frequencies and bandwidths of infrared light are orders of magnitude higher than medical ultrasound signals, resulting in greatly increased image resolution, 8-25 times greater than any existing modality. In addition to providing high-level resolutions for the evaluation of microanatomic structures OCT is also able to provide information regarding tissue composition. ( NCI )] (UMLS (CSP) C0920367) Optical Coherence Tomography =Diagnostic Procedure ;
| - 3182. Dose-Interval Alert
- [Proposed dosage interval/timing differs from standard practice ( HL7V3.0 )] (UMLS (HL7) C1555278) =Intellectual Product =Dosage problem;
=Dose-Interval for Indication Alert;
|
- 3133. Doppler Ultrasound
- [Diagnostic imaging that uses sound waves (ultrasound) applying the Doppler effect, with frequency-shifted ultrasound reflections produced by moving targets (usually red blood cells) in the bloodstream along the ultrasound axis in direct proportion to the velocity of movement of the targets, to determine both direction and velocity of blood flow. ( NCI )] (UMLS (NCI) C0162481) =Diagnostic Procedure
| - 3183. Dose-Interval for Indication Alert
- [Proposed dosage interval/timing differs from standard practice for the identified indication or diagnosis ( HL7V3.0 )] (UMLS (HL7) C1555540) =Intellectual Product =Dose-Interval Alert;
|
- 3134. Doppler velocimetry
- [ ] (UMLS (CSP) C0598596) =Natural Phenomenon or Process
| - 3184. Dosette
- [Special packaging that will help patients take their medications on a regular basis. ( HL7V3.0 )] (UMLS (HL7) C1553470) =Intellectual Product =Compliance Package;
|
- 3135. Dopram
- (UMLS (NCI) C0699979) =Organic Chemical; Pharmacologic Substance ;
| - 3185. dosimetry
- [assay procedure involving measurement of the radiation intensity of a radioactive sample. ( CSP )] (UMLS (NCI) C0034603) =Laboratory Procedure = ;
=scintillation spectrometry |
- 3136. Doqualast
- (UMLS (NCI) C0058704) =Organic Chemical; Pharmacologic Substance
| - 3186. dot blotting
- [ ] (UMLS (CSP) C0013064) =Laboratory Procedure
|
- 3137. Doranidazole
- (UMLS (NCI) C0966231) =Organic Chemical; Pharmacologic Substance ;
| - 3187. DOTATOC
- [A chelated octreotide derivative with somatostatin activity. Edotreotide is produced by substituting tyrosine for phenylalanine at the 3 position of octreotide and chelated via dodecanetetraacetic acid (DOTA). Like octreotide, this edotreotide binds to somatostatin receptors (SSTRs), especially type 2, presence on the cell membrane of many types of neuroendocrine tumors. When labeled with nuclides, edotreotide conjugates could result in tissue specific cytotoxicity. ( NCI )] (UMLS (NCI) C0539568) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
|
- 3138. Doripenem
- (UMLS (NCI) C0389169) =Organic Chemical; Pharmacologic Substance
| - 3188. Double
- [Consisting of or involving two parts or components, often in pairs. ( NCI )] (UMLS (NCI) C0205173) =Functional Concept
|
- 3139. dorsal acoustic stria
- [ ] (UMLS (CSP) C0175454) =Body Part, Organ, or Organ Component
| - 3189. DOUBLE BLIND
- [A clinical trial in which neither the medical staff nor the person knows which of several possible therapies the person is receiving. ( NCI )] (UMLS (NCI) C0013072) =Research Activity
|
- 3140. Dorsal and dorsolumbar fusion, anterior technique
- [ ] (UMLS (ICD9CM) C0186042) =Therapeutic or Preventive Procedure
| - 3190. double layer electric potential
- [ ] (UMLS (CSP) C0599650) =Cell Function ;
|
- 3141. Dorsal and dorsolumbar fusion, posterior technique
- [ ] (UMLS (ICD9CM) C0186044) =Therapeutic or Preventive Procedure
| - 3191. double male syndrome
- [genetic disorder that produces tall and in many cases disturbed behavioral males due to XYY karyotype. ( CSP )] (UMLS (CSP) C0043379) =Congenital Abnormality; Disease or Syndrome =Chromosomal anomalies;
Sex Chromosome Abnormalities;
syndrome;
|
- 3142. Dorsal Cochlear Nucleus
- (UMLS (NCI) C0175499) =Body Part, Organ, or Organ Component
| - 3192. Double Minute 2 Protein
- [Inhibits p53 trans-activation, cell cycle arrest, and apoptosis. MDM2 binds p53 in the cell cycle at S/G2M phase and targets p53 for proteasome-mediated proteolysis. MDM2 also inhibits Rb protein and binds p14(ARF), ribosomal protein L5, and specifically to RNA. MDM2 gene expression is induced by DNA damage and regulated by the Ras-MAP kinase pathway. Some soft tissue sarcomas carry amplified MDM2 and overexpress MDM2 protein. (from SWISS-PROT Q00987, OMIM 164785, and NCI) ( NCI )] (UMLS (NCI) C0971008) HDM2;
MDM 2 Protein;
MDM2;
MDM2 Protein;
p53 Binding Protein;
p53-Binding Protein MDM2;
Ubiquitin-Protein Ligase E3 MDM2;
=Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 3143. dorsal column
- [dorsal portion of the white matter of the spinal cord; consists primarily of axons that relay somatic sensory information to the medulla. ( CSP )] (UMLS (CSP) C0458459) =Body Part, Organ, or Organ Component =Medulla Spinalis;
| - 3193. Double outlet right ventricle
- [Incomplete transposition of the great vessels in which both the AORTA and the PULMONARY ARTERY arise from the RIGHT VENTRICLE. The only outlet of the LEFT VENTRICLE is a large ventricular septal defect (VENTRICULAR SEPTAL DEFECTS or VSD). The various subtypes are classified by the location of the septal defect, such as subaortic, subpulmonary, or noncommitted. ( MSH )] (UMLS (ICD9CM) C0013069) =Congenital Abnormality; Disease or Syndrome ;
=COMPL TRANSPOS GREAT VES;
|
- 3144. dorsal efferent motor nucleus
- [ ] (UMLS (CSP) C1537008) =Body Part, Organ, or Organ Component
| - 3194. DOUBLE PTERYGIUM
- [ ] (UMLS (ICD9CM) C0155157) =Disease or Syndrome
|
- 3145. dorsal horn
- [the dorsal section of the gray matter of the spinal cord; contains sensory nuclei that are relay sites for somatosensory information entering the spinal cord. ( CSP )] (UMLS (CSP) C0228575) =Body Part, Organ, or Organ Component =Medulla Spinalis;
| - 3195. Double Strand Break Repair
- [Mechanisms of DNA repair associated with radiation damage. ( NCI )] (UMLS (NCI) C1158537) Double-Strand Break Repair;
=Genetic Function |
- 3146. Dorsal Horn of the Spinal Cord
- (UMLS (NCI) C0228564) =Body Part, Organ, or Organ Component
| - 3196. double stranded RNA
- [RNA consisting of two strands as opposed to the more prevalent single-stranded RNA; most of the double-stranded segments are formed from transcription of DNA by intramolecular base-pairing of inverted complementary sequences separated by a single-stranded loop; some double-stranded segments of RNA are normal in all organisms. ( CSP )] (UMLS (CSP) C0035693) =Nucleic Acid, Nucleoside, or Nucleotide; Biologically Active Substance =Ribonucleic acid;
|
- 3147. Dorsal Metacarpal Artery
- (UMLS (NCI) C0447094) =Body Part, Organ, or Organ Component
| - 3197. Double Stranded RNA Virus
- [A virus that has double stranded RNA as its genetic material. ( NCI )] (UMLS (NCI) C1005582) dsRNA Virus;
=Virus |
- 3148. Dorsal Metatarsal Vein
- (UMLS (NCI) C0835053) =Body Part, Organ, or Organ Component
| - 3198. DOUBLING OF UTERUS
- (UMLS (ICD9CM) C0152240) =Congenital Abnormality ;
|
- 3149. dorsal motor nucleus
- [parasympathetic nucleus of the medulla; lateral or dorsolateral to the hypoglossal nucleus in the open medulla and dorsal to the hypoglossal nucleus in the closed medulla; composed of small cells supplying preganglionic fibers by way of the vagus (and bulbar accessory) nerves to terminal ganglia for relay to viscera of the thorax and abdomen. ( CSP )] (UMLS (CSP) C0596458) =Body Part, Organ, or Organ Component =medulla oblongata;
| - 3199. Doubt raised
- (UMLS (HL7) C1547322) =Idea or Concept =Allergy Clinical Status;
|
- 3150. Dorsal Nasal Artery
- (UMLS (NCI) C0226194) =Body Part, Organ, or Organ Component
| - 3200. Douche
- [Douche ( HL7V3.0 )] (UMLS (HL7) C1698996) =Functional Concept =RouteByMethod;
=Douche, vaginal;
|
home
